findmyKOL
Clinical trialNCT07288190Not, yet, recruitingPhase 2Interventional

Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR

SponsorHIV Prevention Trials NetworkEnrollment300HIV InfectionsPregnancy
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To evaluate adherence to a single dual-prevention pill (DPP) compared with a two-pill regimen (2PR) for pre-exposure prophylaxis (PrEP) and pregnancy prevention in women without HIV.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Eswatini
  • Eswatini Prevention Center Crs

    Mbabane, Eswatini

Uganda
  • Mu-Jhu Research Collaboration (mujhu Care Ltd) Crs

    Kampala, Uganda

Zimbabwe
  • Spilhaus Crs

    Harare, Zimbabwe

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

2PRDPPFree Choice
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 May 2026
Primary completion
15 May 2028
Completion
15 May 2028
Last update posted
19 Feb 2026
Registered enrollment
300
Registry id
NCT07288190

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.